Precision Biosensor, Inc. (KOSDAQ:335810)
3,120.00
+15.00 (0.48%)
At close: Aug 28, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Clinical Chemical | 12.72B | Log In | Log In | Log In | Log In | Upgrade |
Clinical Chemical Growth | -15.53% | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostic | 6.07B | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostic Growth | 21.48% | Log In | Log In | Log In | Log In | Upgrade |
Goods and Services | 336.00M | Log In | Log In | Log In | Log In | Upgrade |
Goods and Services Growth | 2.75% | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostic Testers and Diagnostic Reagents Manufactured Product | - | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostic Testers and Diagnostic Reagents Manufactured Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostic Testers and Diagnostic Reagents Merchandise | - | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostic Testers and Diagnostic Reagents Merchandise Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Other | 4.13B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 79.13% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 7.34B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | -17.44% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 5.97B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | -0.08% | Log In | Log In | Log In | Log In | Upgrade |
China | 852.42M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -21.60% | Log In | Log In | Log In | Log In | Upgrade |
United States | 836.47M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -60.74% | Log In | Log In | Log In | Log In | Upgrade |
Other | 4.13B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 79.13% | Log In | Log In | Log In | Log In | Upgrade |
Germany | - | Log In | Log In | Log In | Log In | Upgrade |
Germany Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Switzerland | - | Log In | Log In | Log In | Log In | Upgrade |
Switzerland Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Russia | - | Log In | Log In | Log In | Log In | Upgrade |
Russia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Czech Republic | - | Log In | Log In | Log In | Log In | Upgrade |
Czech Republic Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Iran | - | Log In | Log In | Log In | Log In | Upgrade |
Mexico | - | Log In | Log In | Log In | Log In | Upgrade |
Austria | - | Log In | Log In | Log In | Log In | Upgrade |